NCM · Biotechnology

Moolec Science S.A. (MLEC) Stock

$7.37 +2.43% NCM: MLEC Healthcare

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas.

Valuation

MetricValue
Price$7.37
Market Cap$5.35M
P/E Ratio-0.03
P/B Ratio-0.05
P/S Ratio0.02
EPS (TTM)$-258.75
52-Week High$54.00
52-Week Low$3.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE376.84%
ROA-54.45%
ROCE33.43%
Gross Margin-2.99%
Operating Margin-2.99%
Net Margin-33.41%
Debt/Equity-3.74
Current Ratio0.13

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$1.0M$6.0M$334.0M
Operating Profit$0$-2.0M$-7.0M$-9.0M$-10.0M
Net Profit$0$-5.0M$-52.0M$-7.0M$-111.0M
EPS$-0.01$-1.80$-22.50$-2.85$-258.75
Op Margin——-735.2%-160.8%-3.1%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$139.0M$6.0M$24.0M$35.0M$205.0M
Total Liabilities$5.0M$4.0M$14.0M$28.0M$288.0M
Cash$0$1.0M$3.0M$5.0M$1.0M
Borrowings$0$0$3.0M$15.0M$247.0M

Latest News

Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States ACCESS Newswire · May 14, 2026 Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period ACCESS Newswire · May 13, 2026 Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications ACCESS Newswire · Apr 29, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$0$-2.0M$-8.0M$-9.0M$-24.0M
Investing Cash Flow$0$-138.0M$-3.0M$0$-42.0M
Financing Cash Flow$0$0$0$-2.0M$-10.0M
Net Cash Flow$0$0$1.0M$3.0M$-52.0M
Free Cash Flow$0$-2.0M$-8.0M$-9.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA20.95
FCF Yield-560.59%
Quick Ratio0.12
Interest Coverage-0.24
Return 1Y-89.68%
Return 3Y-98.62%
Return 5Y-99.52%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DRMA $1.10 -0.90% -0.15 $749713 0.00%
ELAB $0.92 +2.21% 0.00 $1.78M 0.00%
GLMD $0.62 +3.67% -0.25 $5.13M 0.00%
GTBP $0.29 -4.65% -0.07 $3.12M 0.00%
NCEL $3.60 -4.13% -0.13 $1.62M 0.00%

About Moolec Science S.A.

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.

Moolec Science S.A. is led by CEO Alejandro Antalich, employs 52 people, headquartered in LU, publicly traded since 2021.

Moolec Science S.A. (MLEC) stock trades at $7.37 with a market capitalization of $5.35M. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of -0.05, price-to-sales of 0.02. Over the past 52 weeks the stock has ranged between $3.08 and $54.00, and currently trades 86.4% below its 52-week high.

On profitability, Moolec Science S.A. generates a return on equity (ROE) of 376.84% — well above the market average, a sign of a high-quality business, return on capital employed of 33.43%, an operating margin of -2.99%, a net profit margin of -33.41%.

Official website: www.moolecscience.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides